Abstract:The amount of dose reduction on changing from low dose rate (LDR) brachytherapy to medium dose rate (MDR) or high dose rate (HDR) afterloading has been the subject of much debate. The magnitude of reduction depends, together with other possible factors, on two radiobiological parameters: the alpha/beta ratio and the half-time of repair of the relevant tissues. In an attempt to extract these radiobiological parameters for the late rectal complications observed in our previously published clinical results four different schedules using MDR and one using LDR are analyzed. The percentage incidence of complications was a function of increasing biologically effective dose (BED), but would yield nonsense scattergrams if plotted against raw total dose. In addition, for three other published MDR series, three LDR series, and two HDR series, the incidence of rectal complications is plotted against BED to examine the predictive potential of using BED as the surrogate of total dose. Our own results were published in 1996, consisting of 102 patients treated at the LDR of 0.44 Gy/hr and 88 patients treated by four different schedules using an MDR of 1.6-1.7 Gy/hr. Follow-up is at least 3 years in all schedules. The linear quadratic formula including the "g" dose rate factor was used to analyze them, assuming exponential repair of the repairable beta term. First, multivariate and profile likelihood analyses were carried out to obtain estimates of alpha/beta and T1/2 for rectal late responding tissues. Then graphs of incidence of rectal complications vs. BED were constructed, assuming alpha/beta = 3 Gy and T1/2 = 1.5 hr, values which had not been contradicted by the multivariate analysis. Graphs were drawn both for "all grades including mild reactions" (grades 1 + 2 + 3) and for "serious" complications (grade 3 in our system). In addition, other published cervical brachytherapy series were reviewed, with calculation of their BEDs if not published by the authors. It was necessary to review and compare their grading systems, so that "mild and moderate" (grades 1 and 2) could be contrasted with "serious" (grades 3 and 4 or 5 in various systems). Comparisons were made with other published results, including three LDR, three MDR, and two HDR series spanning from 1982 to 1997. The BEDs at which the incidence of rectal complications rose above the arbitrary level of 10% were compared for all three ranges of dose rate. The multivariate analysis gave estimates of alpha/beta and T1/2 which were not significantly different from 3 Gy and 1.5 hr, respectively, so these values were used to compute the BEDs for the subsequent comparisons. It was found that the graphs of incidence of rectal complications for "all grades including mild" agreed rather better between all series than might have been expected, within a provisional (10%) threshold BED of range 100-123 Gy3 (60-74 Gy given as 2 Gy fractionated external beam or as LDR). The dose-response curves diverged above these values, as expected until common grading systems such as SOMA/ LENT become more widely used. For "serious" complications the 10% incidence occurred at a median BED of 140 Gy3 (84 Gy given as 2 Gy fractionated external beam or as LDR), range 124-155 Gy3. The use of BED (or extrapolated response dose), assuming alpha/beta = 3 Gy and T1/2 = 1.5 hr, instead of total dose, enabled incidence of late rectal complications in cervical brachytherapy with LDR, MDR, and HDR to be plotted in a reasonably consistent way. This does not mean that those parameter values have been definitively determined, but they appear to be provisional values that may be of use in comparing the expected effects of new schedules until better values are obtained from greater use of common grading systems.

Effective Dose for Patients Undergoing Coronary and Femoral Intravascular Radiotherapy Involving an HDR 192ir Source.

Effective Dose Equivalent for Point Gamma Sources Located 10 Cm Near the Body.

Applications of Tissue Heterogeneity Corrections and Biologically Effective Dose Volume Histograms in Assessing the Doses for Accelerated Partial Breast Irradiation Using an Electronic Brachytherapy Source

The effective dose equivalent and effective dose for hot particles on the skin

Personnel exposure during gamma endovascular brachytherapy

In vitro and preclinical systematic dose-effect studies of Auger electron- and beta particle-emitting radionuclides and external beam radiation for cancer treatment

Radiation Doses in Interventional Radiology Procedures

SU-GG-I-63: Calculations of Organ Doses From Cone-Beam CT IGRT Procedures Using a Suite of Patient Phantoms

Biologically effective doses in medium dose rate brachytherapy of cancer of the cervix

Equivalent uniform RBE‐weighted dose in eye plaque brachytherapy

IPEM topical report: the first UK survey of cone beam CT dose indices in radiotherapy verification imaging for adult patients

Assessment of Patient Organ Doses and Effective Doses Using the VIP-Man Adult Male Phantom for Selected Cone-Beam CT Imaging Procedures During Image Guided Radiation Therapy.

High dose rate 192 Ir brachytherapy source model Monte Carlo dosimetry: mHDR-v2 and mHDR-v2r

Monte Carlo-aided dosimetry of a new high dose-rate brachytherapy source

Monte Carlo Calculations for Reporting Patient Organ Doses from Interventional Radiology

Biologically effective dose calculation of radioactive seed implantation brachytherapy and its clinical application

Image-Guided Brachytherapy a Comparison Between 192Ir and 60Co Sources in Carcinoma Uterine Cervix

A dosimetric comparison of brachytherapy sources for endometrial cancer: an electronic brachytherapy and an iridium-192 source with multichannel cylinders and a three-dimensional technique

Monte Carlo Calculation of Imaging Doses from Diagnostic Multidetector Ct and Kilovoltage Cone-Beam Ct As Part of Prostate Cancer Treatment Plans

Effective dose evaluation for BNCT brain tumor treatment based on voxel phantoms

Radiation Dose Levels for Interventional CT Procedures